Evidence map›Paper›PMID 30986536›Full record

Trial reportContemporary clinical trials2019

A randomized trial to reduce smoking among American Indians in South Dakota: The walking forward study.

Mark B Dignan, Kate Jones, Linda Burhansstipanov, Sheikh I Ahamed, Linda U Krebs, Drew Williams, G M Tanimul Ahsan, Ivor Addo, Michele Sargent, Kristin Cina and 5 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Contemporary clinical trials, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 7 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 7 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Smoking Cessation Interventions in Indigenous North Americans: A Meta-Narrative Systematic Review.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023
    Pooled it
  7. Strategies to improve smoking cessation rates in primary care.The Cochrane database of systematic reviews · 2021
    Pooled it
  8. Efficacy and Utilization of Smartphone Applications for Smoking Cessation Among American Indians and Alaska Natives: Results From the iCanQuit Trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022
    Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Mark B DignanPrevention Research Center, University of Kentucky, Lexington, KY 40522, USA. Electronic address: mark.dignan@uky.edu.
Kate JonesPrevention Research Center, University of Kentucky, Lexington, KY 40522, USA.
Linda BurhansstipanovNative American Cancer Initiatives, Inc., 3022 South Nova Road, Pine, CO 880470-7830, United States of America. Electronic address: LindaB@NatAmCancer.net.
Sheikh I AhamedUbicomp research lab Marquette University, P.O. Box 1881, 1313 W. Wisconsin Avenue, Milwaukee, WI 53201, United States of America. Electronic address: sheikh.ahamed@marquette.edu.
Linda U KrebsNative American Cancer Initiatives, Inc., 3022 South Nova Road, Pine, CO 880470-7830, United States of America. Electronic address: linda.krebs@ucdenver.edu.
Drew WilliamsUbicomp research lab Marquette University, P.O. Box 1881, 1313 W. Wisconsin Avenue, Milwaukee, WI 53201, United States of America.
G M Tanimul AhsanComputer Science, University of Wisconsin - Green Bay, Green Bay, WI 54311, United States of America. Electronic address: ahsang@uwgb.edu.
Ivor AddoCollege of Business, University of Wisconsin - Oshkosh, Oshkosh, WI 54901, United States of America. Electronic address: addoid@uwosh.edu.
Michele SargentAvera Research Institute, Avera Health, 4940 5(th) Street Suite 1C, Rapid City, SD 57701, United States of America. Electronic address: Michele.Sargent@avera.org.
Kristin CinaAvera Research Institute, Avera Health, 4940 5(th) Street Suite 1C, Rapid City, SD 57701, United States of America. Electronic address: Kristin.cina@avera.org.
Kim CrawfordAvera Research Institute, Avera Health, 4940 5(th) Street Suite 1C, Rapid City, SD 57701, United States of America.
Doris ThibeaultAvera Research Institute, Avera Health, 4940 5(th) Street Suite 1C, Rapid City, SD 57701, United States of America. Electronic address: Doris.thibeault@avera.org.
Simone BordeauxAvera Research Institute, Avera Health, 4940 5(th) Street Suite 1C, Rapid City, SD 57701, United States of America. Electronic address: Simone.bordeaux@avera.org.
Shalini KanekarRegional Cancer Care Institute, Rapid City Regional Hospital, 353 Fairmount Blvd, Rapid City, SD 57701, USA; Clinical Affairs, Prometic Biotherapeutics Inc., Rockville, MD 20850, United States of America.
Daniel PetereitRegional Cancer Care Institute, Rapid City Regional Hospital, 353 Fairmount Blvd, Rapid City, SD 57701, USA. Electronic address: DPetereit@regionalhealth.com.
Marquette University · USNative American Cancer Initiatives (United States) · USRapid City Regional Hospital · USUniversity of Kentucky · USUniversity of Wisconsin–Green Bay · USUniversity of Wisconsin–Oshkosh · US

Funding

American Indian mHealth Smoking Dependence study (PQ4)R01CA170336 · NCI · RAPID CITY REGIONAL HOSPITAL · PI PETEREIT, DANIEL G · 2012 to 2015
$1.9M
NCI NIH HHS R01 CA170336
6 · The paper itself

Abstract

backgroundLung cancer is an important public health issue, particularly among American Indians (AIs). The reported decline in tobacco use for most racial/ethnic groups is not observed among AIs. This project was designed to address the research question, "Why don't more Northern Plains American Indians alter tobacco use behaviors known to increase the risk of cancer?"

methodsGuided by the Theory of Planned Behavior, a multi-component intervention study was implemented. Adult AIs, age 18 years or older and currently smoking, were enrolled. Eligible subjects were randomized to one of 15 groups and exposed to either a MINIMAL or an INTENSE level of 4 intervention components. The intervention was delivered face-to-face or via telephone by Patient Navigators (PN). The primary outcome was self-reported abstinence from smoking verified by carbon monoxide measurement.

resultsAt 18 months post-quit date, 88% of those who were still in the study were abstinent. This included 6% of all participants who enrolled in the study (14/254) and 13% of those who made it to the quit date (14/108). No intervention groups were found to have significant proportions of participants who were abstinent from smoking at the quit date (visit 5) or primary outcome visit (18 months post-quit date, visit 11), but use of pharmacologic support for abstinence was found to be an effective strategy for individuals who continued participation throughout the study. Those who remained in the study received more visits and were more likely to be abstinent.

conclusionsUse of NRT increased the odds of not smoking, as assessed at the 18-month follow-up visit, but no other interventions were found to significantly contribute to abstinence from smoking. Although the intervention protocol included numerous points of contact between CRRs and participants (11 visits) loss to follow-up was extensive with only 16/254 remaining enrolled. Additional research is needed to improve understanding of factors that influence enrollment and retention in smoking cessation interventions for AI and other populations.

Indexed as

Indians, North AmericanAdolescentAdultAgedAged, 80 and overBehavior TherapyFemaleHumansMaleMiddle AgedSmoking CessationSocioeconomic FactorsSouth DakotaTelemedicineTobacco Use Cessation DevicesYoung Adult

Identifiers

PMID30986536
PMCPMC6608583
OpenAlexW2937873837

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.